News & Updates

Diabetic kidney disease (DKD) is a global healthcare burden. At a symposium co-organized by Diabetes Hongkong and Hong Kong Society of Nephrology, Professor Ronald Ma of the Chinese University of Hong Kong discussed the current landscape of DKD in Hong Kong, and Dr Masayuki Yamanouchi, a specialist in nephrology from Toranomon Hospital in Tokyo, Japan, discussed clinical and real-world evidence on the effects of a nonsteroidal mineralocorticoid receptor antagonist (MRA), finerenone, in improving outcomes in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). Dr Yamanouchi also presented two patient cases to illustrate the clinical benefits of finerenone in DKD patients with different disease severity.

Lifestyle interventions, including increased fibre intake, have been shown to be effective in management of metabolic diseases. At a meeting coordinated by the Hong Kong College of Family Physicians (HKCFP), Dr Elaine Chow of the Department of Medicine & Therapeutics, the Chinese University of Hong Kong, described different types of dietary fibre and their various benefits, and shared clinical evidence on the role of psyllium fibre in minimizing cardiometabolic risk factors, such as elevated LDL-cholesterol (LDL-C), blood glucose levels and obesity.